RecruitingNot applicableNCT06079294
Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism
Studying OBSOLETE: Other forms of non-paraneoplastic limbic encephalitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- Aurélie Kas, PrHôpital Pitié Salpêtrière - Assistance Publique Hôpitaux de Paris
- Intervention
- FDG PET(other)
- Enrollment
- 56 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2026
Study locations (1)
- Hospital Pitie Salpetriere, Paris, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06079294 on ClinicalTrials.govOther trials for OBSOLETE: Other forms of non-paraneoplastic limbic encephalitis
Additional recruiting or active studies for the same condition.
See all trials for OBSOLETE: Other forms of non-paraneoplastic limbic encephalitis →